Perceptive Advisors »

Newamsterdam Pharma Co Nv shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.1M 175k 23.65

More positions owned by Perceptive Advisors

Cerevel Therapeutics Hldng I (CERE)
Amicus Therapeutics (FOLD)
Arcellx Common Stock (ACLX)
Iovance Biotherapeutics (IOVA)
Nuvalent Inc-a (NUVL)
Rhythm Pharmaceuticals (RYTM)
Vaxcyte (PCVX)
Soleno Therapeutics (SLNO)
Intra Cellular Therapies (ITCI)
Immatics SHS (IMTX)
Neurocrine Biosciences (NBIX)
Apogee Therapeutics (APGE)
Madrigal Pharmaceuticals (MDGL)
CryoLife (AORT)
Spyre Therapeutics Com New (SYRE)

View all positions for Perceptive Advisors

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
RA Capital Management
Viking Global Investors
Medicxi Ventures Management
Cormorant Asset Management
Adage Capital Partners GP
BVF
Polar Capital Holdings
Millennium Management
Henderson Group
GMT Capital Corp
Jennison Associates
Deerfield Management Company

View all funds holding Newamsterdam Pharma Co Nv